Sign In

FDA Approves Paradise Renal Denervation System for Hypertension

Core Concepts
Paradise Ultrasound Renal Denervation system approved by FDA for hypertension treatment.
The FDA has approved the Paradise Ultrasound Renal Denervation system for treating hypertension. The approval was based on positive reviews by the FDA's Circulatory Systems Device panel. Data from the RADIANCE program and trials supported the approval. Renal denervation is an adjunctive treatment option for hypertension control when lifestyle changes and medication are insufficient. The system delivers ultrasound energy to denervate sympathetic nerves around renal arteries, reducing hypertension. The Paradise system offers significant blood pressure reductions and is beneficial for patients with resistant or mild to moderate hypertension.
The Paradise Ultrasound Renal Denervation system delivers two to three doses of 360-degree ultrasound energy through each main renal artery. The system is water-cooled to protect the renal artery wall.
"Given the significant blood pressure reductions seen in the ultrasound renal denervation trials, the Paradise Ultrasound Renal Denervation system offers a much-needed advancement in our currently available options to control hypertension." - Naomi Fisher, MD

Key Insights Distilled From

by Susan Jeffre... at 11-08-2023
FDA OKs Paradise Renal Denervation System for Hypertension

Deeper Inquiries

How does renal denervation compare to other treatment options for hypertension?

Renal denervation offers a unique approach to treating hypertension compared to traditional methods like medication and lifestyle changes. While medications aim to control blood pressure through systemic effects, renal denervation targets the sympathetic nerves surrounding the renal arteries to reduce overactivity that contributes to hypertension. This targeted approach can be particularly beneficial for patients with resistant hypertension who do not respond well to medications or cannot tolerate them. Additionally, renal denervation can provide long-lasting effects, potentially reducing the need for multiple medications or frequent adjustments in treatment regimens.

What are the potential drawbacks or limitations of using ultrasound renal denervation for hypertension control?

Despite its promising results, ultrasound renal denervation also has potential drawbacks and limitations. One limitation is the need for specialized equipment and trained healthcare professionals to perform the procedure, which may limit its accessibility in certain healthcare settings. Additionally, the long-term effects and durability of blood pressure reduction achieved through renal denervation are still being studied, raising questions about the sustainability of its benefits over time. Furthermore, like any medical procedure, renal denervation carries risks of complications such as renal artery injury or stenosis, highlighting the importance of careful patient selection and monitoring.

How can advancements in medical devices like the Paradise system impact the future of hypertension management?

Advancements in medical devices such as the Paradise Ultrasound Renal Denervation system have the potential to revolutionize hypertension management by offering a novel and effective treatment option for patients with uncontrolled or resistant hypertension. By providing a non-pharmacological alternative that targets the underlying mechanisms of hypertension, devices like the Paradise system can fill a crucial gap in current treatment strategies. This can lead to improved blood pressure control, reduced reliance on medications, and better outcomes for patients who have struggled to achieve adequate blood pressure management through traditional means. Additionally, the introduction of innovative devices like the Paradise system may pave the way for further developments in the field of interventional cardiology and hypertension treatment, shaping the future of patient care in this area.